OBJECTIVE: To compare rates of complications associated with cesarean delivery in HIV-infected and HIV-uninfected women in the United States and to investigate trends in such complications across four study cycles spanning the implementation of HAART in the United States (1995-1996, 2000-2001, 2005-2006, 2010-2011). DESIGN: The Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project is the largest all-payer hospital inpatient care database in the United States; when weighted to account for the complex sampling design, nationally representative estimates are derived. After restricting the study sample to women aged 15-49 years, our study sample consisted of approximately 1 090 000 cesarean delivery hospitalizations annually. METHODS: Complications associated with cesarean deliveries were categorized as infection, hemorrhage, or surgical trauma, based on groups of specific International Classification of Diseases 9th revision codes. Length of hospitalization, hospital charges, and in-hospital deaths were also examined. RESULTS: The rate of complications significantly decreased during the study periods for HIV-infected and HIV-uninfected women. However, rates of infectious complications and surgical trauma associated with cesarean deliveries remained higher among HIV-infected, compared with HIV-uninfected women in 2010-2011, as did prolonged hospital stay and in-hospital deaths. Length of hospitalization decreased over time for cesarean deliveries of HIV-infected women to a greater extent compared with HIV-uninfected women. CONCLUSION: In the United States, rates of cesarean delivery complications decreased from 1995 to 2011. However, rates of infection, surgical trauma, hospital deaths, and prolonged hospitalization are still higher among HIV-infected women. Clinicians should remain alert to this persistently increased risk of cesarean delivery complications among HIV-infected women.
OBJECTIVE: To compare rates of complications associated with cesarean delivery in HIV-infected and HIV-uninfectedwomen in the United States and to investigate trends in such complications across four study cycles spanning the implementation of HAART in the United States (1995-1996, 2000-2001, 2005-2006, 2010-2011). DESIGN: The Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project is the largest all-payer hospital inpatient care database in the United States; when weighted to account for the complex sampling design, nationally representative estimates are derived. After restricting the study sample to women aged 15-49 years, our study sample consisted of approximately 1 090 000 cesarean delivery hospitalizations annually. METHODS: Complications associated with cesarean deliveries were categorized as infection, hemorrhage, or surgical trauma, based on groups of specific International Classification of Diseases 9th revision codes. Length of hospitalization, hospital charges, and in-hospital deaths were also examined. RESULTS: The rate of complications significantly decreased during the study periods for HIV-infected and HIV-uninfectedwomen. However, rates of infectious complications and surgical trauma associated with cesarean deliveries remained higher among HIV-infected, compared with HIV-uninfectedwomen in 2010-2011, as did prolonged hospital stay and in-hospital deaths. Length of hospitalization decreased over time for cesarean deliveries of HIV-infectedwomen to a greater extent compared with HIV-uninfectedwomen. CONCLUSION: In the United States, rates of cesarean delivery complications decreased from 1995 to 2011. However, rates of infection, surgical trauma, hospital deaths, and prolonged hospitalization are still higher among HIV-infectedwomen. Clinicians should remain alert to this persistently increased risk of cesarean delivery complications among HIV-infectedwomen.
Authors: J S Read; R Tuomala; E Kpamegan; C Zorrilla; S Landesman; G Brown; M Vajaranant; H Hammill; B Thompson Journal: J Acquir Immune Defic Syndr Date: 2001-03-01 Impact factor: 3.731
Authors: J P Ioannidis; E J Abrams; A Ammann; M Bulterys; J J Goedert; L Gray; B T Korber; M J Mayaux; L M Mofenson; M L Newell; D E Shapiro; J P Teglas; C M Wilfert Journal: J Infect Dis Date: 2001-01-12 Impact factor: 5.226
Authors: A Vimercati; P Greco; G Loverro; P L Lopalco; V Pansini; L Selvaggi Journal: Eur J Obstet Gynecol Reprod Biol Date: 2000-05 Impact factor: 2.435
Authors: Lisa M Bebell; Joseph Ngonzi; Mark J Siedner; Winnie R Muyindike; Bosco M Bwana; Laura E Riley; Yap Boum; David R Bangsberg; Ingrid V Bassett Journal: AIDS Care Date: 2018-02-16
Authors: Lyson Tenthani; Joep J van Oosterhout; Andreas D Haas; Malango Msukwa; Nozgechi Phiri; Frank Chimbwandira; Kali Tal; Karoline Aebi-Popp; Janne Estill; Olivia Keiser Journal: BMC Pregnancy Childbirth Date: 2018-04-12 Impact factor: 3.007